Loss of Mouse P2Y6 Nucleotide Receptor Is Associated with Physiological Macrocardia and Amplified Pathological Cardiac Hypertrophy

被引:22
|
作者
Clouet, Sophie [1 ]
Di Pietrantonio, Larissa [1 ]
Daskalopoulos, Evangelos-Panagiotis [2 ]
Esfahani, Hrag [3 ]
Horckmans, Michael [1 ]
Vanorle, Marion [1 ]
Lemaire, Anne [1 ]
Balligand, Jean-Luc [3 ]
Beauloye, Christophe [2 ]
Boeynaems, Jean-Marie [1 ,4 ]
Communi, Didier [1 ]
机构
[1] Univ Libre Bruxelles, IRIBHM, Inst Interdisciplinary Res, B-1070 Brussels, Belgium
[2] Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Cardiovasc Res, B-1200 Brussels, Belgium
[3] Catholic Univ Louvain, Unit Pharmacol & Therapeut, UCL FATH 5349, B-1200 Brussels, Belgium
[4] Univ Libre Bruxelles, Erasme Hosp, Dept Lab Med, B-1070 Brussels, Belgium
关键词
UTP REDUCES INFARCT; MYOCARDIAL HYPERTROPHY; KNOCKOUT MICE; NATRIURETIC PEPTIDES; HEART FUNCTION; RAT-HEART; CARDIOMYOCYTES; EXPRESSION; ISCHEMIA; PROTEINS;
D O I
10.1074/jbc.M115.684118
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The study of the mechanisms leading to cardiac hypertrophy is essential to better understand cardiac development and regeneration. Pathological conditions such as ischemia or pressure overload can induce a release of extracellular nucleotides within the heart. We recently investigated the potential role of nucleotide P2Y receptors in cardiac development. We showed that adult P2Y(4)-null mice displayed microcardia resulting from defective cardiac angiogenesis. Here we show that loss of another P2Y subtype called P2Y(6), a UDP receptor, was associated with a macrocardia phenotype and amplified pathological cardiac hypertrophy. Cardiomyocyte proliferation and size were increased in vivo in hearts of P2Y(6)-null neonates, resulting in enhanced postnatal heart growth. We then observed that loss of P2Y(6) receptor enhanced pathological cardiac hypertrophy induced after isoproterenol injection. We identified an inhibitory effect of UDP on in vitro isoproterenol-induced cardiomyocyte hyperplasia and hypertrophy. The present study identifies mouse P2Y(6) receptor as a regulator of cardiac development and cardiomyocyte function. P2Y(6) receptor could constitute a therapeutic target to regulate cardiac hypertrophy.
引用
收藏
页码:15841 / 15852
页数:12
相关论文
共 50 条
  • [21] P2Y1, P2Y2, P2Y6, and P2Y12 nucleotide receptor subtypes expression during C6 glioma cell differentiation
    Garcia-Colon, JO
    Cruz, A
    Rubio, M
    Aquino, EE
    Miranda, JD
    Gonzalez, FA
    Silva, WI
    FASEB JOURNAL, 2006, 20 (05): : A1286 - A1286
  • [22] Diisothiocyanate derivatives as potent, insurmountable antagonists of P2y6 nucleotide receptors
    Mamedova, LK
    Joshi, BV
    Gao, ZG
    von Kügelgen, I
    Jacobson, KA
    BIOCHEMICAL PHARMACOLOGY, 2004, 67 (09) : 1763 - 1770
  • [23] Knockout of the P2Y6 Receptor Prevents Peri-Infarct Neuronal Loss after Transient, Focal Ischemia in Mouse Brain
    Milde, Stefan
    Brown, Guy C.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (04)
  • [24] Pyrimidinergic receptor P2Y6 expression is elevated in lung adenocarcinoma and is associated with poor prognosis
    Wang, Xiuli
    Zhao, Baoshan
    Ren, Dan
    Hu, Xiaolei
    Qiao, Juanjuan
    Zhang, Dongmei
    Zhang, Yanzhi
    Pan, Yu
    Fan, Yuhua
    Liu, Lili
    Wang, Xiaoxue
    Ma, Huanhuan
    Jia, Xueling
    Song, Sihang
    Zhao, Chong
    Liu, Jingbo
    Wang, Lin
    CANCER BIOMARKERS, 2023, 38 (02) : 191 - 201
  • [25] P2Y6 receptor and immunoinflammationP2Y6受体与免疫炎症
    Gui-Dong Liu
    Jian-Qing Ding
    Qin Xiao
    Sheng-Di Chen
    Neuroscience Bulletin, 2009, 25 : 161 - 164
  • [26] Knockout of purinergic receptor Y6 (P2Y6) leads to cardiomyopathy in mice
    Ahmed, I.
    Merz, J.
    Rofa, K.
    Dufner, B.
    Schickmeier, J.
    Hoppe, N.
    Hilgendorf, I.
    Bode, C.
    Zirlik, A.
    Stachon, P.
    EUROPEAN HEART JOURNAL, 2018, 39 : 593 - 593
  • [27] Mapping the Binding Sites of UDP and Prostaglandin E2 Glyceryl Ester in the Nucleotide Receptor P2Y6
    Zimmermann, Anne
    Vu, Oanh
    Brueser, Antje
    Sliwoski, Gregory
    Marnett, Lawrence J.
    Meiler, Jens
    Schoeneberg, Torsten
    CHEMMEDCHEM, 2022, 17 (07)
  • [28] Effect Of A Purinergic P2y6 Receptor Agonist On Airway remodeling And Responsiveness in A Mouse Model Of asthma
    Chetty, A.
    Sharda, A.
    Warburton, R.
    Chen, T.
    Xue, C.
    Castellot, J.
    Haydon, P. G.
    Nielsen, H. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [29] Synthesis and structure-activity relationship of uracil nucleotide derivatives as antagonists of human P2Y6 receptor
    Meltzer, Diana
    Ben Yaacov, Ofir
    Arguin, Guillaume
    Nadel, Yael
    Gendron, Fernand-Pierre
    Fischer, Bilha
    PURINERGIC SIGNALLING, 2014, 10 (04) : 783 - 783
  • [30] Enhancement of Glucose Uptake in Mouse Skeletal Muscle Cells and Adipocytes by P2Y6 Receptor Agonists
    Balasubramanian, Ramachandran
    Robaye, Bernard
    Boeynaems, Jean-Marie
    Jacobson, Kenneth A.
    PLOS ONE, 2014, 9 (12):